Dr. Bourdette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-7321- Is this information wrong?
Education & Training
Oregon Health & Science UniversityResidency, Neurology, 1979 - 1982
Santa Clara Valley Medical CenterInternship, Internal Medicine, 1978 - 1979
University of California, Davis, School of MedicineClass of 1978
Certifications & Licensure
OR State Medical License 1980 - 2025
MP State Medical License 2017 - 2019- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Trial of Memantine for Cognitive Impairment in Multiple Sclerosis Start of enrollment: 2004 Apr 01
- Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis Start of enrollment: 2009 Jan 01
- Effects of Training on Central Auditory Function in Multiple Sclerosis Start of enrollment: 2007 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- The Challenges of Treating Late-Onset Multiple Sclerosis.Bourdette, D., Wooliscroft, L.> ;Neurology. 2024 Mar 26
- 1 citationsRituximab for Multiple Sclerosis: Hiding in Plain SightAnnette Langer-Gould, Elias S Sotirchos, Dennis Bourdette> ;Neurology. 2024 Jan 23
- What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?Dennis Bourdette, Elizabeth Silbermann> ;Neurology. 2023 Nov 14
- Join now to see all
Journal Articles
- Hypothalamic-Pituitary-Thyroid Axis Perturbations in Male Mice by CNS-Penetrating ThyromimeticsDennis Bourdette, MD, Endocrinology
Press Mentions
Newly Discovered Compound Could Repair Myelin Fibres and Prevent the Progression of Neurodegenerative DiseasesMarch 18th, 2022- Guillain-Barre Risk up Slightly After ShingrixNovember 1st, 2021
- Guillain-Barré Case Reported After Covid-19 VaccinationApril 9th, 2021
- Join now to see all
Grant Support
- Small Molecules Targeting The Mitochondrial Permeability TransitionNational Institute On Drug Abuse2012
- Lipoic Acid Therapy For Experimental Autoimmune EncephalomyelitisVeterans Affairs2011–2012
- Mitochondrial Modulation For Neuroprotection In A Model Of Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2008–2012
- Jungers Center New Faculty Recruitment In Genetic Models Of Axonal DegenerationNational Institute Of Neurological Disorders And Stroke2009–2010
- Study To Evaluate The Role Of An Oral Antioxidant, Alpha Lipoic Acid In MSNational Center For Research Resources2004
- Natural Antioxidant In The Treatment Of MSNational Center For Complementary &Alternative Medicine1999
Professional Memberships
- Fellow
- American Neurological AssociationFellow
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
